S&P, Nasdaq Composite hit records as Pfizer vaccine gets FDA approval

The S&P 500 and Nasdaq Composite hit record highs on Monday as travel and medical stocks surged after the Food and Drug Administration granted full approval to Pfizer’s COVID-19 vaccine.